PMID: 18725450DOI: 10.1128/aac.00245-08Aug 30, 2008Paper
Characterization of TolC efflux pump proteins from Pasteurella multocida.
Antimicrobial Agents and Chemotherapy
Tamas HatfaludiB Adler
Abstract
Two TolC homologs, PM0527 and PM1980, were identified for Pasteurella multocida. A pm0527 mutant displayed increased susceptibility to a range of chemicals, including rifampin (512-fold) and acridine orange (128-fold). A pm1980 mutant showed increased susceptibility to rifampin, ceftazidime, and vancomycin.
References
Jul 1, 1991·Agricultural and Biological Chemistry·R UtsumiM Noda
Nov 2, 1992·Gene·F DuongM Murgier
Dec 1, 1992·Journal of Bacteriology·D H Nies
Jun 1, 1988·Journal of Bacteriology·V L Miller, J J Mekalanos
Oct 1, 1995·Journal of Bacteriology·C WassifR Belas
Nov 1, 1995·Journal of Bacteriology·H AkatsukaT Shibatani
Oct 1, 1993·Journal of Bacteriology·D MaJ E Hearst
Aug 1, 1996·Molecular Microbiology·K PooleT Nishino
Jan 1, 1996·Biochimie·G Perrière, M Gouy
Oct 1, 1996·Molecular Microbiology·R Binet, C Wandersman
Dec 1, 1996·Computer Applications in the Biosciences : CABIOS·N GaltierC Gautier
Feb 28, 1998·Nucleic Acids Research·J D ThompsonD G Higgins
Mar 12, 1999·Journal of Bacteriology·J H AhnJ S Rhee
Jun 22, 1999·Journal of Molecular Biology·Y ZhangK Geider
Nov 26, 1999·Gene·M T HassanM Mergeay
Feb 15, 2000·Journal of Bacteriology·G GrassD H Nies
Mar 4, 2000·Veterinary Microbiology·I W WilkieA J Frost
Jul 6, 2000·Nature·V KoronakisC Hughes
Mar 28, 2001·EMBO Reports·C AndersenV Koronakis
Mar 30, 2001·Veterinary Microbiology·M CárdenasUNKNOWN Molecular Microbiology Group
Jul 17, 2001·Current Opinion in Cell Biology·C AndersenV Koronakis
Oct 26, 2001·Nature·M McClellandR K Wilson
Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Xian-Zhi LiKeith Poole
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·Jun LinQijing Zhang
Jul 23, 2003·Infection and Immunity·Jun LinQijing Zhang
Aug 23, 2003·Infection and Immunity·Marina HarperBen Adler
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Catherine M Trepod, John E Mott
Apr 10, 2004·Microbiology·A M ProutyJ S Gunn
May 25, 2004·Infection and Immunity·Marina HarperBen Adler
Oct 7, 2004·Nature Genetics·Christel CazaletCarmen Buchrieser
Oct 28, 2004·The Journal of Biological Chemistry·Hiroyuki AkamaTaiji Nakae
Feb 3, 2005·The Journal of Biological Chemistry·Luca FedericiAdrian R Walmsley
Dec 24, 2005·Proteomics·John D BoyceBen Adler
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis
Apr 14, 2006·Cellular Microbiology·Anthony M BuckleyLaura J V Piddock
Jun 1, 2006·Microbiology·Georg Polleichtner, Christian Andersen
Jun 1, 2006·Proteins·Arun S KonagurthuArthur M Lesk
Jul 18, 2006·Nature Reviews. Microbiology·Laura J V Piddock
Jan 20, 2007·Microbial Cell Factories·Keith Al-HasaniBen Adler
May 23, 2007·Infection and Immunity·Marina HarperBen Adler
❮ Previous
Next ❯
Citations
Jul 14, 2012·PloS One·Tamás HatfaludiBen Adler
Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Mar 4, 2010·Veterinary Microbiology·Tamás HatfaludiBen Adler
Mar 20, 2015·Clinical Microbiology Reviews·Xian-Zhi LiHiroshi Nikaido
Feb 9, 2021·PLoS Pathogens·Hea-Jin JungEric G Pamer
Feb 19, 2021·Chemical Reviews·Valentin V RybenkovMohammad Moniruzzaman
❮ Previous
Next ❯
Related Concepts
Related Feeds
CRISPR Screens in Drug Resistance
CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.
Related Papers
Avian Diseases
Louisa B Tabatabai
Biochimica Et Biophysica Acta
Muriel MasiJean-Marie Pagès
Infection and Immunity
Diana M PosadasAngeles Zorreguieta